logo
logo

Phylos Closes $7.6 Million In Funding To Scale Market-Validated Cannabis And Hemp Genetics And Unveils New Executive Team To Drive Industry Innovation

Feb 01, 2022•over 3 years ago

Amount Raised

$7.6 Million

Portland

Description

Phylos®, a modern crop science company developing advanced Cannabis and hemp genetics, announces the close of its growth funding round totaling $7.6M led by Merida Capital Holdings. Other major investors in the round include Accomplice and Entourage Effect Capital. This infusion further validates a refreshed direction and executive team. Funds will be used in part to expand sales and marketing efforts for Phylos' market-validated Cannabis and hemp genetics

Company Information

Company

Phylos

Location

Portland, Oregon, United States

About

The company has expanded its flagship AutoCBD™ autoflower hemp seed to four varieties and has developed ground-breaking low-touch, high-yield, and disease resistant early maturation Cannabis seed genetics for commercial-scale grows. The company also provides no-cost technology licensing for academic institutions and non-profits, specifically for research purposes. We are confident that Phylos is at the forefront of this movement towards a healthier plant and a more sustainable industry."